EMG

ETF Managers Group Portfolio holdings

AUM $3.1B Turnover 42.86%
1-Year Est. Return 17.12%
This Fund
S&P 500
This Quarter Est. Return
-7.64%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
-$816M
Cap. Flow
-$82.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
17.57%
Holding
743
New
97
Increased
366
Reduced
207
Closed
70
Avg Time Held
1.7 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
VALT
ETFMG Sit Ultra Short ETF
VALT
+$49.8M
2
NABL icon
N-able
NABL
+$49.3M
3
S icon
SentinelOne
S
+$26.5M
4
BB icon
BlackBerry
BB
+$23M
5
MQ icon
Marqeta
MQ
+$21.6M

Top Sells

Rank Stock Value
1
MNDT
Mandiant, Inc. Common Stock
MNDT
+$53.4M
2
PFPT
Proofpoint, Inc.
PFPT
+$50.7M
3
TPB icon
Turning Point Brands
TPB
+$45.7M
4
MAG
MAG Silver
MAG
+$29.1M
5
GRWG icon
GrowGeneration
GRWG
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 47.43%
2 Materials 12.97%
3 Healthcare 12.03%
4 Financials 8.36%
5 Miscellaneous 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SQZ
626
DELISTED
SQZ Biotechnologies Company
SQZ
$146K ﹤0.01%
10,131
+1,907
+23% +$25.8K
2020 Q4
3 quarters
INTA icon
627
Intapp
INTA
$3.01B
$141K ﹤0.01%
+5,529
New +$180K
2021 Q3
0 quarters
ACEL icon
628
Accel Entertainment
ACEL
$900M
$137K ﹤0.01%
+11,227
New +$129K
2021 Q3
0 quarters
MEOH icon
629
Methanex
MEOH
$4.9B
$130K ﹤0.01%
+2,777
New +$100K
2021 Q3
0 quarters
LNAI icon
630
Lunai Bioworks
LNAI
$4.36M
$126K ﹤0.01%
236
+60
+34% +$29.3K
2020 Q3
4 quarters
TE icon
631
T1 Energy
TE
$875M
$126K ﹤0.01%
+12,356
New +$114K
2021 Q3
0 quarters
SPRY icon
632
ARS Pharmaceuticals
SPRY
$400M
$125K ﹤0.01%
11,809
+1,514
+15% +$37.3K
2021 Q1
2 quarters
CDAK
633
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$125K ﹤0.01%
7,768
+1,265
+19% +$22.6K
2020 Q4
3 quarters
GTLS icon
634
DELISTED
Chart Industries
GTLS
$121K ﹤0.01%
+621
New +$107K
2021 Q3
0 quarters
NFE icon
635
New Fortress Energy
NFE
$21.8M
$115K ﹤0.01%
+86
New +$130K
2021 Q3
0 quarters
ADN icon
636
DELISTED
Advent Technologies
ADN
$114K ﹤0.01%
+448
New +$109K
2021 Q3
0 quarters
ATHX
637
DELISTED
Athersys, Inc. Common Stock
ATHX
$107K ﹤0.01%
3,137
+515
+20% +$19.6K
2020 Q2
5 quarters
BLDP icon
638
Ballard Power Systems
BLDP
$597M
$104K ﹤0.01%
+7,535
New +$119K
2021 Q3
0 quarters
LHDX
639
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$104K ﹤0.01%
14,130
+2,750
+24% +$23.2K
2021 Q1
2 quarters
IMNM icon
640
Immunome
IMNM
$2.04B
$101K ﹤0.01%
4,200
+729
+21% +$12.7K
2021 Q1
2 quarters
CODX icon
641
Co-Diagnostics
CODX
$5.73M
$99K ﹤0.01%
339
+57
+20% +$16.6K
2020 Q2
5 quarters
ZETA icon
642
Zeta Global
ZETA
$8.15B
$97K ﹤0.01%
+17,923
New +$114K
2021 Q3
0 quarters
AFCG icon
643
AFC Gamma
AFCG
$67.4M
$95K ﹤0.01%
+6,500
New +$94.3K
2021 Q3
0 quarters
PRTK
644
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$85K ﹤0.01%
17,173
+3,329
+24% +$18.3K
2020 Q2
5 quarters
IBIO icon
645
iBio
IBIO
$49.8M
$81K ﹤0.01%
153
+24
+19% +$14.9K
2020 Q2
5 quarters
TNXP icon
646
Tonix Pharmaceuticals
TNXP
$112M
– –
0
– –
2021 Q1
2 quarters
CRMD icon
647
CorMedix
CRMD
$582M
$66K ﹤0.01%
14,170
+2,935
+26% +$17.1K
2020 Q2
5 quarters
HOOK icon
648
DELISTED
HOOKIPA Pharma
HOOK
$66K ﹤0.01%
1,092
+213
+24% +$15.4K
2020 Q2
5 quarters
EVAX icon
649
Evaxion A/S
EVAX
$25.2M
$64K ﹤0.01%
137
+24
+21% +$8.2K
2021 Q1
2 quarters
INSG icon
650
Inseego
INSG
$70.5M
$63K ﹤0.01%
949
-5,205
-85% -$435K
2020 Q2
5 quarters
24 25
26
27 28

Similar funds

AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
PFM
Parsec Financial Management Asheville, North Carolina $2.37B AUM 4.66% 1-Year Est. Return
DKP
Davidson Kempner Partners New York $5.16B AUM
HT
HighTower Trust Houston, Texas $1.02B AUM 4.1% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
QA
Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return
BFG
Barber Financial Group Lenexa, Kansas $567M AUM 5.25% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

ETF Managers Group's Q3 2021 Portfolio in Review

As of Q3 2021, ETF Managers Group held 743 positions worth $5.32B, down 13% from $6.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ETF Managers Group's Q3 2021 filing shows 97 new, 366 increased, 207 reduced and 70 closed positions. Its largest new stake was N-able: 3,597,911 shares worth $44.8M. The largest sale was Mandiant, Inc. Common Stock, an estimated $53.4M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Materials and Healthcare.

  • ETF Managers Group's largest Q3 2021 buy was N-able: 3,597,911 shares worth $44.8M.
  • ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q3 2021, an estimated $49.8M increase.
  • ETF Managers Group's biggest Q3 2021 reduction was MAG Silver, cutting an estimated $29.1M.
  • ETF Managers Group fully exited Mandiant, Inc. Common Stock in Q3 2021, selling an estimated $53.4M.
  • ETF Managers Group's ten largest holdings make up 18% of its $5.32B portfolio in Q3 2021.
  • ETF Managers Group opened 97 new positions and closed 70 in Q3 2021.
  • ETF Managers Group's portfolio value fell 13% quarter-over-quarter to $5.32B.

Based on ETF Managers Group's 13F filing for Q3 2021, filed 15 Nov 2021.